These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12768464)

  • 21. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning regimen in children: a single-center experience.
    Strullu M; Rialland F; Cahu X; Brissot E; Corradini N; Thomas C; Blin N; Rialland X; Méchinaud F; Mohty M
    Eur J Haematol; 2012 Jun; 88(6):504-9. PubMed ID: 22372430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic artery resistance index at doppler ultrasonography is a useful parameter of hepatic graft-vs-host disease after allogeneic stem cell transplantation.
    Song MK; Chung JS; Kim S; Seol YM; Kim SG; Shin HJ; Choi YJ; Cho GJ
    Transplant Proc; 2010 Nov; 42(9):3717-22. PubMed ID: 21094845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for human herpesvirus 6 reactivation and its relationship with syndrome of inappropriate antidiuretic hormone secretion after stem cell transplantation in pediatric patients.
    Toriumi N; Kobayashi R; Yoshida M; Iguchi A; Sarashina T; Okubo H; Suzuki D; Sano H; Ogata M; Azuma H
    J Pediatr Hematol Oncol; 2014 Jul; 36(5):379-83. PubMed ID: 23929317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A survey of general dental practitioners in the North West of England concerning the dental care of patients following head and neck radiotherapy.
    Husein AB; Butterworth CJ; Ranka MS; Kwasnicki A; Rogers SN
    Prim Dent Care; 2011 Apr; 18(2):59-65. PubMed ID: 21457625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-2 therapy after bone marrow or stem cell transplantation for hematologic malignancies.
    Fefer A; Robinson N; Benyunes MC; Bensinger WI; Press O; Thompson JA; Lindgren C
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S48-53. PubMed ID: 9457394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different Impact of the Number of Organ Failures and Graft-Versus-Host Disease on the Outcome of Allogeneic Stem Cell Transplantation Recipients Requiring Intensive Care.
    Orvain C; Beloncle F; Hamel JF; Thépot S; Mercier M; Kouatchet A; Farhi J; Francois S; Guardiola P; Asfar P; Hunault-Berger M; Mercat A; Ifrah N; Tanguy-Schmidt A
    Transplantation; 2017 Feb; 101(2):437-444. PubMed ID: 26950729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dental management of pediatric patients undergoing hematopoietic stem cell transplant.
    Yamagata K; Onizawa K; Yoshida H; Yamagata K; Kojima Y; Koike K; Tsuchida M
    Pediatr Hematol Oncol; 2006; 23(7):541-8. PubMed ID: 16928649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Value of FDG PET/CT before Allogeneic and Autologous Stem Cell Transplantation for Aggressive Lymphoma.
    Ulaner GA; Goldman DA; Sauter CS; Migliacci J; Lilienstein J; Gönen M; Schöder H; Moskowitz CH; Zelenetz AD
    Radiology; 2015 Nov; 277(2):518-26. PubMed ID: 26035588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies.
    Ozdemir E; Saliba RM; Champlin RE; Couriel DR; Giralt SA; de Lima M; Khouri IF; Hosing C; Kornblau SM; Anderlini P; Shpall EJ; Qazilbash MH; Molldrem JJ; Chemaly RF; Komanduri KV
    Bone Marrow Transplant; 2007 Jul; 40(2):125-36. PubMed ID: 17530009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation.
    Gaballa S; Palmisiano N; Alpdogan O; Carabasi M; Filicko-O'Hara J; Kasner M; Kraft WK; Leiby B; Martinez-Outschoorn U; O'Hara W; Pro B; Rudolph S; Sharma M; Wagner JL; Weiss M; Flomenberg N; Grosso D
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):141-8. PubMed ID: 26415558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial.
    Ribera JM; Oriol A; Bethencourt C; Parody R; Hernández-Rivas JM; Moreno MJ; del Potro E; Torm M; Rivas C; Besalduch J; Sanz MA; Ortega JJ;
    Haematologica; 2005 Oct; 90(10):1346-56. PubMed ID: 16219571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT.
    Ruutu T; de Wreede LC; van Biezen A; Brand R; Mohty M; Dreger P; Duarte R; Peters C; Garderet L; Schönland S; Gratwohl A; Niederwieser D; de Witte T; Kröger N;
    Bone Marrow Transplant; 2015 Dec; 50(12):1542-50. PubMed ID: 26367221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study.
    Runde V; Ross S; Trenschel R; Lagemann E; Basu O; Renzing-Köhler K; Schaefer UW; Roggendorf M; Holler E
    Bone Marrow Transplant; 2001 Jul; 28(1):51-7. PubMed ID: 11498744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation.
    Picardi A; Fabritiis Pd Pd; Cudillo L; Dentamaro T; Cupelli L; Ballatore G; Venditti A; Caravita T; Cristina Cox M; Catalano G; Amadori S
    Hematol J; 2004; 5(1):24-31. PubMed ID: 14745426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced.
    Shimoni A; Yeshurun M; Hardan I; Avigdor A; Ben-Bassat I; Nagler A
    Biol Blood Marrow Transplant; 2004 Jul; 10(7):484-93. PubMed ID: 15205669
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem cell transplantation for the treatment of advanced hematologic malignancies.
    Sobecks RM; Daugherty CK; Hallahan DE; Laport GF; Wagner ND; Larson RA
    Bone Marrow Transplant; 2000 Apr; 25(8):807-13. PubMed ID: 10808200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequelae and complications related to dental extractions in patients with hematologic malignancies and the impact on medical outcome.
    Raut A; Huryn JM; Hwang FR; Zlotolow IM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jul; 92(1):49-55. PubMed ID: 11458245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Safety Outcomes in Patients with Hematological Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplantation Treated with Palifermin to Prevent Oral Mucositis.
    Stiff PJ; Leinonen M; Kullenberg T; Rudebeck M; de Chateau M; Spielberger R
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):164-9. PubMed ID: 26303102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.